A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis

EMBO Journal

Volumn 16, Issue 14, 1997, Pages 4384-4392

  Israeli, David ^a   Tessler, Ellen ^a   Haupt, Ygal ^b   Elkeles, Adi ^a   Wilder, Sylvia ^a   Amson, Robert ^c   Telerman, Adam ^c   Oren, Moshe ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c FONDATION JEAN DAUSSET CEPH   (France)

Author keywords

Apoptosis; p53 tumor suppressor; PAG608; Zinc finger protein

Indexed keywords

DNA; NUCLEAR PROTEIN; PROTEIN P53; ZINC FINGER PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL STRUCTURE; CONTROLLED STUDY; DNA DAMAGE; GENE INDUCTION; GENETIC ANALYSIS; GENETIC TRANSFECTION; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TRANSACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BASE SEQUENCE; BLOTTING, NORTHERN; CLONING, MOLECULAR; DNA FRAGMENTATION; DNA-BINDING PROTEINS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; ZINC FINGERS;

ANIMALIA;

EID: 0030802364     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.14.4384     Document Type: Article

References (51)

1. Amson, R.B. et al. (1996) Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the Drosophila seven in absentia gene. Proc. Natl Acad. Sci. USA, 93, 3953-3957.
2. Attardi, L.D., Lowe, S.W., Brugarolas, J. and Jacks, T. (1996) Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J., 15, 3693-3701.
3. Barak, Y., Juven, T., Haffner, R. and Oren, M. (1993) mdm2 expression is induced by wild type-p53 activity. EMBO J., 12, 461-468.
4. Bates, S. and Vousden, K.H. (1996) p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev., 6, 12-18.
5. Brugarolas, J., Chandrasekaran, C., Gordon, J.I., Beach, D., Jacks, T. and Hannon, G.J. (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature, 377, 552-557.
6. Buckbinder, L., Talbott, R., Velascomiguel, S., Takenaka, I., Faha, B., Seizinger, B.R. and Kley, N. (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature, 377, 646-649.
7. Caelles, C., Helmberg, A. and Karin, M. (1994) p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature, 370, 220-223.
8. Cavanaugh, A.H., Hempel, W.M., Taylor, L.J., Rogalsky, V., Todorov, G. and Rothblum, L.I. (1995) Activity of RNA polymerase I transcription factor UBF blocked by RB gene product. Nature, 374, 177-180.
9. Chen, X., Ko, L.J., Jayaraman, L. and Prives, C. (1996) p53 levels, functional domains, and DNA damage extent determine the extent of the apoptotic response of tumor cells. Genes Dev., 10, 2438-2451.
10. Clarke, A.R., Purdie, C.A., Harrison, D.J., Morris, R.G., Bird, C.C., Hooper, M.L. and Wyllie, A.H. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature, 362, 849-852.
11. Darzynkiewicz, Z. (1995) Apoptosis in antitumor strategies: modulation of cell cycle or differentiation. J. Cell Biochem., 58, 151-159.
12. Deng, C.X., Zhang, P.M., Harper, J.W., Elledge, S.J. and Leder, P. (1995) Mice lacking p21(C/P1/WAF1) undergo normal development, but are defective in G1 checkpoint control. Cell, 82, 675-684.
13. Friedlander, P. Haupt, Y., Prives, C. and Oren, M. (1996) A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol. Cell. Biol., 16, 4961-4971.
14. Gottlieb, T.M. and Oren, M. (1996) p53 in growth control and neoplasia. Biochim. Biophys Acta, 1287, 77-102.
15. Haffner, R. and Oren, M. (1995) Biochemical properties and biological effects of p53. Curr. Opin. Genet. Dev., 5, 84-90.
16. Haupt, Y. and Oren, M. (1996) p53-mediated apoptosis: mechanisms and regulation. Behring Istitute Mitteilungen, 97, 32-59.
17. Haupt, Y., Rowan, S. and Oren, M. (1995a) p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. Oncogene, 10, 1563-1571.
18. Haupt, Y., Rowan, S., Shaulian, E., Vousden, K.H. and Oren, M. (1995b) Induction of apoptosis in HeLa cells by transactivation-deficient p53. Genes Dev., 9, 2170-2183.
19. Haupt, Y. Barak, Y. and Oren, M. (1996) Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J., 15, 1596-1606.
20. Hiebert, S.W., Packham, G., Strom, D.K., Haffner, R., Oren, M., Zambetti, G. and Cleveland, J.L. (1995) E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol. Cell. Biol., 15, 6864-6874.
21. Johnson, P. Chung, S. and Benchimol, S. (1993) Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin. Mol. Cell. Biol., 13, 1456-1463.
22. Karasuyama, H. and Melchers, F. (1988) Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol., 18, 97-84.
23. Ko, L.J. and Prives, C. (1996) p53: puzzle and paradigm. Genes Dev., 10, 1054-1072.
24. Liang, P. and Pardee, A.B. (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Nature, 257, 967-971.
25. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A. and Jacks, T. (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847-849.
26. Ludwig, R.L., Bates, S. and Vousden, K.H. (1996) Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol. Cell. Biol., 16, 4952-4960.
27. Maheswaran, S., Englert, C. Bennett, P., Heinrich, G. and Haber, D.A. (1995) The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev., 9, 2143-2156.
28. Michalovitz, D., Halevi, O. and Oren, M. (1990) Conditional inhibition of transformation and of cell proliferation by temperature-sensitive mutant of p53. Cell, 62, 671-680.
29. Miyashita, T. and Reed, J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299.
30. Miyashita, T., Krajewski, S., Krajewska, M. Wang, H.G., Lin, H.K., Liebermann, D.A., Hoffman, B. and Reed, J.C. (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9, 1799-1805.
31. Momand, J., Zambetti, G.R. Olson, D.C., George, D. and Levine, A.J. (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237-1245.
32. Nemani, M. et al. (1996) Activation of the human homologue of the Drosofila sina gene in apoptosis and tumor suppression. Proc. Natl Acad. Sci. USA, 93, 9039-9042.
33. Okamoto, K. and Beach, D. (1994) Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J., 13, 4816-4822.
34. Oliner, J.D., Kinzler, K.W., Meltzer, P.S., George, D.L. and Vogelstein, B. (1992) Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature, 358, 80-83.
35. Oren, M. and Prives, C. (1996) p53: upstream, downstream and off stream. Biochim. Biophys. Acta, 1288, R13-R19.
36. Rowan, S., Ludwig, R.L., Haupt, Y., Bates, S., Lu, X., Oren, M. and Vousden, K.H. (1996) Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO J., 15, 827-838.
37. Sabbatini, P., Lin, J.Y., Levine, A.J. and White, E. (1995) Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev., 9, 2184-2192.
38. Selvakumaran, M., Lin, H.K., Miyashita, T., Wang, H.G., Krajewski, S., Reed, J.C., Hoffman, B. and Liebermann, D. (1994) Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene, 9, 1791-1798.
39. Smith, M.L., Chen, I.T., Zhan, Q.M., Bae, I.S., Chen, C.Y., Gilmer, T.M., Kastan, M.B., O'Connor, P.M. and Fornace, A.J. (1994) Interaction of the p53-regulated protein GADD45 with proliferating cell nuclear antigen. Science, 266, 1376-1380.
40. Su, L., Hershberger, R.J. and Weissman, I.L. (1993) LYAR, a novel nucleolar protein with zinc finger DNA-binding motifs, is involved in cell growth regulation. Genes Dev., 7, 735-748.
41. Waldman, T., Lengauer, C., Kinzler, K.W. and Vogelstein, B. (1996) Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature, 381, 713-716.
42. Wales, M.M., Biel, M.A., Eldeiry, W., Nelkin, B.D., Issa, R. Cavenee, W.K., Kuerbitz, S.J. and Baylin, S.B. (1995) p53 activates expression of HIC-1, a new candidate tumour suppressor aene on 17p13.3. Nature Med., 1, 570-577.
43. Wang, X.W. et al. (1996) The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev., 10, 1219-1232.
44. White, E. (1996) Life, death, and the pursuit of apoptosis. Genes Dev., 10, 1-15.
45. Wu, X.W., Bayle, J.H., Olson, D. and Levine, A.J. (1993) The p53 mdm-2 autoregulatory feedback loop. Genes Dev., 7, 1126-1132.
46. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A. and Oren, M. (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature, 352, 345-347.
47. Yonish-Rouach, E., Grunwald, D., Wilder, S., Kimchi, A., May, E., Lawrence, J.J., May, P. and Oren, M. (1993) p53-mediated cell death -relationship to cell cycle control. Mol. Cell. Biol., 13, 1415-1423.
48. Yonish-Rouach, E., Deguin, V., Zaitchouk, T., Breugnot, C. Mishal, Z., Jenkins, J.R. and May, E. (1995) Transcriptional activation plays a role in the induction of apoptosis by transiently transfected wild-type p53. Oncogene, 11, 2197-2205.
49. Zauberman, A., Barak, Y., Ragimov, N., Levy, N. and Oren, M. (1993) Sequence-specific DNA binding by p53 - identification of target sites and lack of binding to p53-MDM2 complexes. EMBO J., 12, 2799-2808.
50. Zauberman, A., Lupo, A. and Oren, M. (1995) Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene contains two distinct p53 binding sites. Oncogene, 10, 2361-2366.
51. Zhao, S., Ooi, S.L., Yang, F.-C. and Pardee, A.B. (1996) Three methods for identification of true positive cloned cDNA fragments in differential display. Biotechniques, 20, 402-406.